Heron Therapeutics, Inc. (HRTX)

Heron Therapeutics, Inc. (HRTX) is a healthcare company (biotechnology) based in the United States. The share price is $0.28, down 0.74% on the day, which values the company at $53.7M. Price as of 18 Nov 2026, 12:31 UTC, from Yahoo Finance.

Key facts

Share price
$0.28−0.74% today
Market value
$53.7M
Funk Score
39/100
Against its own history
Well below its usual priceusual price $1.51
200-week average
$1.6383% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Heron Therapeutics, Inc. in more detail

HRTX trades at -2.4× next year's expected earnings, 0.4× sales. Measured against its own history, the price is 81% below what its usual multiples would imply ($1.51) — well below its usual price. It sits 83% below its 200-week average of $1.63.

Over the last five fiscal years Heron Therapeutics, Inc. has compounded revenue 11.8% a year. Its Funk Score is 39 out of 100 (financial strength 1.5, profitability 2.0, growth 7.1, value 5.0, each out of 10).

In its favour: Operating margin is expanding. Worth checking: Altman Z in the distress zone; Weak Piotroski score.

Heron Therapeutics, Inc. (HRTX): questions and answers

What is Heron Therapeutics, Inc.'s market cap?

Heron Therapeutics, Inc. is valued at $53.7M at a share price of $0.28.

Is HRTX overvalued or undervalued?

Against its own history, HRTX is well below its usual price: the price is 81% below the $1.51 implied by the median multiples it has traded at (price / sales, price / book). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is HRTX above its 200-week moving average?

No. HRTX is 82.6% below its 200-week average of $1.63. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Heron Therapeutics, Inc. growing?

Over the last five fiscal years Heron Therapeutics, Inc.'s revenue grew 11.8% a year.

Does HRTX pay a dividend?

Heron Therapeutics, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Heron Therapeutics, Inc. (HRTX) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/HRTX

Underlying data: Yahoo Finance; company filings with the SEC.